Status:
COMPLETED
Investigation of the Effect of Erector Spinae Plane Block on Systemic Immuno-Inflammatory Index
Lead Sponsor:
Namik Kemal University
Conditions:
Erector Spinae Plane Block
Systemic Immune-inflammatory Index
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
Erector spinae plane block (ESPB) is a novel interfascial block technique first described by Forero in 2016. It has been reported to be effective in various clinical indications. In ESPB, local anesth...
Eligibility Criteria
Inclusion
- Female patients aged 18-75 years
- ASA (American Society of Anesthesiologists) physical status I-II-III
- Undergoing unilateral breast cancer surgery under general anesthesia
- Volunteered to participate in the study and signed informed consent
Exclusion
- Allergy or contraindication to local anesthetics
- Coagulopathy or on anticoagulant therapy
- Infection at the injection site
- History of chronic pain or opioid use
- Neurological or psychiatric disorders affecting pain perception
- Refusal to receive regional anesthesia
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06954324
Start Date
March 15 2021
End Date
February 1 2023
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Namik Kemal University
Tekirdağ, Turkey (Türkiye), 59020